Cypress
Cypress
Cypress, California, United States14 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2026-10-09 | NCT06672055 | |
| A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epistaxis, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformation | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT06659640 | |
| A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants | Healthy Volunteer | Recruiting | Phase 1 | 2026-09-15 | NCT07219030 | |
| First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671 | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 / Phase 2 | 2026-09-14 | NCT07815678 | |
| Phase 1 Study Involving SAB01 and Healthy Participants | Healthy Adult Participants | Recruiting | Phase 1 | 2026-09-11 | NCT07815561 | |
| A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-08-18 | NCT07710768 | |
| Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected) | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-07-21 | NCT07225816 | |
| Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects | Healthy; Safety and Tolerability | Active, not recruiting | Phase 1 | 2026-06-03 | NCT05997641 | |
| A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 / Phase 2 | 2026-06-01 | NCT06924320 | |
| A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Phase 3 | 2026-04-30 | NCT06161571 | |
| A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 2 | 2026-04-21 | NCT07395687 | |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011 | Bunyaviridae infectious disease, Digestive System Diseases, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Rift valley fever, arbovirus infection, hepatitis, hepatitis, non-human animal, hepatitis, viral, animal, liver disorder, non-human animal disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 1 | 2026-03-25 | NCT06925919 | |
| A Study of SPY003-207 in Healthy Volunteers | Healthy | Active, not recruiting | Phase 1 | 2026-03-20 | NCT06873724 | |
| Phase 1 Study of SBS-147 in Healthy Adults | Acute Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Phase 1 | 2026-03-03 | NCT07335913 |